VEOLIA (EPA:VIE) | Finanzwire

BRIEF

published on 09/06/2024 at 09:27, 2 months 15 days ago

BlackRock exceeds 5% of Veolia Environnement capital

Voting Rights Capital BlackRock Threshold Crossing Veolia Environment
BRIEF

published on 09/05/2024 at 15:08, 2 months 16 days ago

BlackRock reduces its stake in VEOLIA ENVIRONNEMENT

Voting Rights Actions Veolia BlackRock Crossing Thresholds
BRIEF

published on 09/04/2024 at 18:44, 2 months 16 days ago

Veolia Environnement Reports Voting Rights and Share Capital Information

Share Capital Voting Rights French Regulations Treasury Shares Veolia Environnement
PRESS RELEASE

published on 09/04/2024 at 18:39, 2 months 16 days ago

Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital
Veolia Environnement reports total number of voting rights as of August 31, 2024. The company discloses 726,148,514 theoretical voting rights and 715,822,225 exercisable voting rights

Share Capital Voting Rights French Commercial Code AMF Veolia Environnement
BRIEF

published on 09/04/2024 at 09:04, 2 months 17 days ago

Veolia completes its campaign to detect PFAS in drinking water in France

Innovation Veolia Treatment PFAS Drinking Water
BRIEF

published on 09/02/2024 at 21:46, 2 months 18 days ago

Veolia Successfully Returns to Senior Bond Market

Financial Strength Veolia Senior Bond EUR 500 Million Ecological Transformation
PRESS RELEASE

published on 09/02/2024 at 21:41, 2 months 18 days ago

Inside Information / Other news releases
Veolia successfully returns on senior bond market with a EUR 500 million bond issue. Positive market response showcases strong confidence in Veolia's credit quality and financial strength

Financial Strength Veolia Credit Quality EUR 500 Million Senior Bond Market
BRIEF

published on 09/02/2024 at 09:43, 2 months 19 days ago

BlackRock crosses thresholds at Veolia Environnement

Capital Actions BlackRock Crossing Thresholds Veolia Environment
BRIEF

published on 08/30/2024 at 11:03, 2 months 22 days ago

BlackRock Crosses Thresholds in Veolia

Voting Rights Capital Veolia BlackRock Crossing Thresholds
BRIEF

published on 08/28/2024 at 18:45, 2 months 23 days ago

BlackRock exceeds 5% of VEOLIA capital

Capital Actions Veolia BlackRock Crossing Thresholds

Published on 11/21/2024 at 16:30, 37 minutes ago

The Rise of DINKs: Dual-Income Couples Without Kids Redefine Financial Priorities in America
Published on 11/21/2024 at 16:01, 1 hour 6 minutes ago

Career Certified Extends Its Investment in the Fast-Growing Architecture, Engineering, and Construction (AEC) Professionals Market with Acquisition of My Contractors License
Published on 11/21/2024 at 16:00, 1 hour 7 minutes ago

Financial Independence Group Announces Exclusive Partnership With Power of Zero and Tax-Free Retirement Expert David McKnight
Published on 11/21/2024 at 16:00, 1 hour 7 minutes ago

Wiz Acquires Dazz to Revolutionize Cloud Security Remediation
Published on 11/21/2024 at 16:00, 1 hour 7 minutes ago

Isaac Ullatil Joins Wellstack Board of Directors

View all ACCESSWIRE

Published on 11/21/2024 at 16:00, 1 hour 7 minutes ago

Director/PDMR Shareholding
Published on 11/21/2024 at 15:41, 1 hour 25 minutes ago

Edison issues report on Murray Income Trust (MUT)
Published on 11/21/2024 at 15:24, 1 hour 43 minutes ago

Form 8.3 - The Vanguard Group, Inc.: International Paper Company
Published on 11/21/2024 at 15:23, 1 hour 44 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Centamin plc
Published on 11/21/2024 at 15:22, 1 hour 45 minutes ago

Form 8.3 - The Vanguard Group, Inc.: TI Fluid Systems plc

View all EQS

Published on 11/21/2024 at 06:58, 10 hours 9 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 21 hours 47 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 23 hours 22 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 23 hours 22 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 9 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE

News